Discover investment opportunities in AI Pharmaceutical Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in AI Pharmaceutical Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in AI Pharmaceutical Stocks using our Smart AI Filter.
10 stocks found for "AI Pharmaceutical Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.92 | ±85.0% | -11.8 | 0.00% | |||
0.59 | ±31.6% | 34.5 | 0.77% | |||
0.30 | ±26.0% | 12.1 | 0.66% | |||
0.36 | ±26.9% | 24.5 | 0.00% | |||
0.83 | ±70.5% | -3.5 | 0.00% | |||
0.45 | ±25.0% | 14.4 | 3.19% | |||
0.35 | ±28.9% | 6.7 | 5.29% | |||
0.64 | ±28.2% | 69.3 | 0.00% | |||
1.19 | ±53.7% | -156.9 | 0.00% | |||
0.32 | ±24.8% | 8.7 | 6.75% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How has the biotech industry influenced the performance of BIIB over the last decade?
A: Biogen (BIIB) has been significantly influenced by the biotech boom, driven by advancements in neurological treatments. However, it faces challenges from patent expirations and regulatory pressures. Historically, the company has seen periods of rapid growth due to successful drug approvals but must navigate ongoing competitive and legislative landscapes.
Q: What role does innovation play in the success of VRTX?
A: Vertex Pharmaceuticals (VRTX) is known for its commitment to innovation, particularly in cystic fibrosis treatments. This focus on groundbreaking therapies has helped drive substantial market performance. Although R&D costs are high, their innovative successes have resulted in strong financial returns and established significant market positions.
Q: How does REGN's focus on monoclonal antibodies impact its market reputation?
A: Regeneron Pharmaceuticals (REGN) is recognized for its pioneering work in monoclonal antibodies, enhancing its reputation as a leader in innovative treatments. Its development of high-impact drugs like Dupixent has strengthened investor confidence and contributed to robust financial results.
Q: What implications does LLY's pricing strategy have on its stock performance?
A: Eli Lilly (LLY) employs a pricing strategy that balances accessibility and profitability. While competitive pricing of key medicines can pressure margins, innovative drug offerings and global expansion sustain growth, contributing to stock stability in diverse markets.
Q: How does MRNA's involvement in mRNA technology affect its growth potential?
A: Moderna (MRNA) has positioned itself as a leader in mRNA technology, significantly boosting growth potential. This technology underpins their COVID-19 vaccine success and promises expansion into other therapeutic areas, influencing investor expectations and share price fluctuation.
Q: What dividend strategies are typical for BMY and how might they appeal to investors?
A: Bristol-Myers Squibb (BMY) employs a strategy of consistent dividend payments, appealing to income-focused investors. This stable payout policy, backed by robust cash flows from a diverse pharmaceutical portfolio, offers a reliable income stream amidst volatile markets.